Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Dr. Prem Aggarwal

Dr Prem Aggarwal, (MD Medicine, DNB Cardiology) is a Cardiologist by profession and also the Co-founder and Chairman of Medical. He focuses on news and perspectives about cardiology, and medicine related developments at Medical Dialogues. He can be reached out at drprem@medicaldialogues.in

Home

Dr. Prem Aggarwal

Articles By : Dr. Prem Aggarwal

Mineralocorticoid Receptor Antagonists offer great economic value in HF patients: AHA/ACC/HFSA 2022.

Dr. Prem Aggarwal28 April 2022 12:45 PM IST

Mineralocorticoid Receptor Antagonists (MRA) have a great potential economic value to offer in patients with Heart Failure with mild ejection fraction...

Perindopril, Amlodipine, and Indapamide combination significantly lowers Blood Pressure: Brisighella Heart Study

Dr. Prem Aggarwal28 April 2022 12:45 PM IST

Italy: Triple combination of perindopril/amlodipine/indapamide lowers blood pressure (BP) and preserves patients' metabolic profile better than all...

Evolocumab to impact coronary disease in statin-treated patients: Glasgov Trial

Dr Prem Agarwal14 Feb 2022 6:30 PM IST

Coronary diseases are much fatal as the buildup of plaque in the arteries that supply oxygen-rich blood to heart creates blockage. Plaque causes a...

Apixaban a better choice of drug than Rivarobaxan in Atrial Fibrillation- How?

Dr. Nandita Mohan11 Jan 2022 10:45 AM IST

There is an interesting research which states that apixaban is a much better drug of choice than Rivaroxaban in adults with atrial fibrillation (AF)...

Pharmacological Treatment of Diabetes: ADA 2022 explores beyond metformin as initial therapy

Dr. Prem Aggarwal24 Dec 2021 4:00 PM IST

New Delhi: Metformin has been the cornerstone of Diabetes management for a long time. However, with the growing research in the field of diabetes and...

Catheter ABlation vs ANtiarrhythmic Drug Therapy in Atrial Fibrillation CABANA trial

Ruchika Sharma7 Dec 2021 5:33 PM IST

Radiofrequency ablation for atrial fibrillation (AF) is an "economically attractive" option compared with drug therapy, according to a new...

Empagliflozin retains benefits in 'True' HFpEF Patients

Ruchika Sharma3 Dec 2021 5:31 PM IST

Empagliflozin provides a wide range of benefits in patients with "true" heart failure and preserved ejection fraction (HFpEF) , meaning an LVEF of 50%...

Oral PCSK9 inhibitor may significantly reduce LDL C levels: DALLAS, The First Human Trial

Dr. Prem Aggarwal3 Dec 2021 2:07 PM IST

Low-density lipoprotein (LDL) cholesterol, popularly known as bad cholesterol is major cause of heart disease. LDL C causes build-up of fatty deposits...

Empagliflozin safe in acute HF, improves 'Clinical Benefit' over time

Dr. Nandita Mohan2 Dec 2021 10:42 AM IST

Patients with acute heart failure were safely started on empagliflozin a median of 3 days after hospitalization and were 36% more likely to...

Ticagrelor can be discontinued 2-3 days prior to CABG without increasing Bleeding Risk

Dr. Nandita Mohan30 Nov 2021 2:25 PM IST

According to new randomized data, in patients with ACS, performing CABG within a couple of days after ticagrelor cessation is noninferior to waiting 5...

Apolipoprotein B emerges as best lipid predictor for Myocardial Infarction risk

Dr. Nandita Mohan28 Nov 2021 10:30 AM IST

The risk of myocardial infarction in patients with and without atherosclerosis is best predicted by the number of apolipoprotein B (apoB)-containing...

Guideline update ACC 2021: Diagnostic evaluations and considerations of chest pain

Dr. Prem Aggarwal18 Nov 2021 5:19 PM IST

The recently issued clinical practice guidelines by ACC for the evaluation and diagnosis of chest pain provide recommendations and algorithms for...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok